PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation
OncoTargets and Therapy2021Vol. Volume 14, pp. 481–489
Citations Over TimeTop 13% of 2021 papers
Marie Beck Enemark, Ida Monrad, Charlotte Bernhard Madsen, Kristina Lystlund Lauridsen, Bent Honoré, Trine Lindhardt Plesner, Stephen Hamilton‐Dutoit, Francesco d’Amore, Maja Ludvigsen
Abstract
Our data suggest that pre-treatment tumor-tissue PD-1 expression already predicts the risk of subsequent transformation to DLBCL, as early as the time of FL diagnosis.
Related Papers
- → Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies(2013)65 cited
- → The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease(2012)38 cited
- → Molecular and immunohistochemical characterization of B-cell lymphoma-2–negative follicular lymphomas(2011)9 cited
- → Composite follicular lymphoma and classic Hodgkin lymphoma(2021)7 cited
- → European Cup Trial(1996)1 cited